Bausch Health Companies | SCHULD



Debt Veränderung Datum
Amgen USD 57.38B 2.72B 2025-03
ANI Pharmaceuticals USD 622.82M 1.27M 2025-03
Aurora Cannabis CAD 100.98M 11K 2024-12
Bausch Health Companies USD 21.51B 106M 2025-03
Biogen USD 6.3B 2M 2025-03
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Canopy Growth CAD 489.67M 123.85M 2024-12
Corcept Therapeutics USD 0 0 2025-03
Danaher USD 16.48B 472M 2025-03
Drreddys Laboratories INR 51.08B 2.55B 2024-12
Eli Lilly USD 38.52B 4.87B 2025-03
Gilead Sciences USD 26.71B 3.46B 2024-12
Novo Nordisk 118.72B 61.75B 2025-03
Pacira USD 583.38M 1.94M 2025-03
Perrigo USD 3.63B 9.4M 2025-03
Prestige Brands USD 1.02B 18.52M 2025-03
Supernus Pharmaceuticals USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Zoetis USD 6.58B 7M 2025-03



Bausch Health Companies SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.